JP Morgan lowered the price target for the Constellium SE (NYSE:CSTM) stock from ‘an Overweight’ to ‘a Neutral’. The rating was released on December 10, 2021, according to finviz. The research report from Goldman has initiated the stock to Buy, with a price target set at $25. The stock was initiated by JP Morgan, who disclosed in a research note on April 23, 2021, to Overweight and set the price objective to $18. In their research brief published March 22, 2021, Northland Capital analysts upgraded the Constellium SE stock from Market Perform to Outperform with a price target of $21.